Tienilic acid (INN and BAN) or ticrynafen (USAN) is a loop diuretic drug with uric acid-lowering (uricosuric) action, formerly marketed for the treatment of hypertension. It was approved by FDA on May 2, 1979, and withdrawn in 1982, after case reports in the United States indicated a link between the use of ticrynafen and hepatitis.

CAS：40180-04-9
中文别名：2,3-二氯-4-(2-噻吩甲酰基)苯氧基乙酸;噻吩利尿酸;2-(2,3-二氯-4-(噻吩-2-羰基)苯氧基)乙酸;
英文别名：[2,3-dichloro-4-(2-thenoyl)phenoxy]acetic acid;[2,3-dichloro-4-(thiophene-2-carbonyl)-phenoxy]-acetic acid;Thienylic acid;Ticrex;Diflurex;Acido tienilico;2-[2,3-dichloro-4-(thiophene-2-carbonyl)phenoxy]acetic acid;TienilicAcid;Tienilico acido;Acidum tienilicum;2,3-dichloro-4-(thien-2-ylcarbonyl)-phenoxyacetic acid;Tienilic acid;Ticrynafen;Acide tienilique;Selacryn;Ticrynafen Tienylic acid [2,3-Dichloro-4-(2-thienylcarbonyl)phenoxy]-acetic acid;
分子式：C13H8Cl2O4S
分子量：331.171
精确质量：329.952
Psa：91.84
Logp：3.7493

UNII：HC95205SY4

密度：1.532g/cm3
沸点：534.6ºC at 760 mmHg
熔点：148-149ºC
闪点：277.1ºC
折射率：1.632
储存条件：-20ºC Freezer

海关编码：2934999090